Amy LiuinMubadalaVenturesThe next frontier of precision medicine — editing the epigenomeGene editing has taken the biotech world by storm since the initial discovery of CRISPR-Cas9, which holds the promise of a potential…Jul 28, 2023Jul 28, 2023
Amy LiuinMubadalaVenturesBuilding EpiBiologics: Mubadala’s company creation strategyBy Alaa Halawa and Amy LiuMar 22, 2023Mar 22, 2023